Takeda Pharmaceutical Company Limited (NYSE: TAK) disclosed Friday that it has requested regulators to give authorization for the use of the COVID-19 vaccine of...
Novavax, Inc. (NASDAQ: NVAX) has completed the COVID-19 vaccine supply deal with the Commonwealth of Australia. As per the deal, Novavax is scheduled to...
Novavax, Inc. (NASDAQ: NVAX) has provided updates regarding its late-stage coronavirus study. The company has disclosed that it is planning to commence Phase III...
